Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Division of Cardiothoracic Surgery, Department of Surgery, University of Texas Medical Branch, Galveston, Texas 77555-0528, USA.
We report the case of a heart transplant recipient who presented twice in profound cardiogenic shock at Months 4 and 8 post-transplant. She had unsuccessful conventional rejection therapy, but responded dramatically to alemtuzumab salvage therapy. Both times, her recovery onset was strikingly parallel to that described after using alemtuzumab as salvage therapy in renal transplantation. The reported use of alemtuzumab in thoracic organ transplant is rare. We believe this is the first reported case of alemtuzumab as salvage therapy in heart transplantation.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on